Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling ...

Discover how to get Mounjaro for weight loss, its benefits, side effects, pricing, and how Mitolyn can enhance your results.

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Amy Schumer opened up about taking the weight loss drug Mounjaro after previously ‘horrible experience’ while on Wegovy.

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

It is being billed by doctors as the best drug in weight management, compared to similar drugs available in the market ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. With rising ...

Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management.